Published date: 28 November 2024

This notice was replaced on 28 November 2024

This notice does not contain the most up-to-date information about this procurement. The most recent notice is:

Opportunity (published 28 November 2024)

Awarded contract - This means that the contract has been awarded to a supplier.


Contract summary

Industry

  • Health services - 85100000

Location of contract

LS1 4AP

Value of contract

£3,891,000

Procurement reference

CF-2706400D0O000000rwimUAA

Published date

28 November 2024

Closing date

31 March 2024

Closing time

12pm

Contract start date

1 April 2024

Contract end date

31 March 2027

Contract type

Service contract

Procedure type

Negotiated procedure without prior publication (above threshold)

The opportunity was not advertised, because for example only one supplier is capable of delivering the requirement, or due to extreme urgency brought about by unforeseen events.

This procedure can be used for procurements above the relevant contract value threshold.

Contract is suitable for SMEs?

No

Contract is suitable for VCSEs?

No

Description

A MOU has been put in place between NHS England and NICE. The NICE Managed Access team will work in partnership with NHS England Medicines Value ad Access directorate to successfully deliver the managed access schemes ( cancer drug fund and innovative medicines fund).

This has been procured through Regulation 12(7).

Award information

Awarded date

24 October 2024

Contract start date

1 April 2024

Contract end date

31 March 2027

Total value of contract

£3,891,000

This contract was awarded to 1 supplier.

NICE

Address

2 Redman Place, E20 1 JQ

Reference

None

About the buyer

Contact name

Leigh Parker

Address

7-8 Wellington Street
Leeds
LS1 4AP
GB

Email

leigh.parker1@nhs.net